Midatech Pharma Profile

0.78
USD 0.04  5.44%
56%
83%

Midatech Pharma Summary

Midatech Pharma Plc (MTP) is traded on BATS Exchange in USA. It is located in UNITED KINGDOM and employs 85 people. Midatech Pharma is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Micro-Cap' category with total capitalization of 30.38 M. Midatech Pharma Plc runs under Healthcare sector within Biotechnology industry. This company has 61.08 M outstanding shares of which 56.87 K shares are now shorted by investors with about 0.96 days to cover shorted positions. MLP & STRATEGIC E has about 17.46 M in cash with (17.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.57.
Check Midatech Pharma Probability Of Bankruptcy

Ownership Allocation (%)

Midatech Pharma Target Price Odds Analysis

Odds Below 0.775HorizonTargetOdds Above 0.775
84.43%30 days 0.78 15.48%
Based on normal probability distribution, the odds of Midatech Pharma to move above current price in 30 days from now is about 15.48% (This Midatech Pharma Plc probability density function shows the probability of Midatech Pharma Stock to fall within a particular range of prices over 30 days) .

Midatech Pharma Plc Top Holders

Midatech Pharma Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Old Mission Capital Llc 1Common Shares41.8 K29 K
Citadel Advisors LlcCommon Shares26.9 K19 K
View Midatech Pharma Diagnostics

Midatech Pharma Plc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Midatech Pharma Key Fundamentals

Midatech Pharma Against Markets

Midatech Pharma Current Ratings

Midatech Pharma Plc 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
11 
Chance of
Financial Distress (0 to 100%)
31 
Equity ratings for Midatech Pharma Plc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Midatech Pharma PLC, a specialty pharmaceutical company, focuses on developing and commercializing products in oncology and immunotherapy in the United States and the United Kingdom. Midatech Pharma PLC was founded in 2000 and is headquartered in Abingdon, the United Kingdom. Midatech Pharma operates under Biotechnology classification in USA and traded on BATS Exchange. It employs 85 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Midatech Pharma Plc SEC Filings
Midatech Pharma SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameMidatech Pharma Plc
CEO, DirectorJames PhillipsView All
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Biotechnology
InstrumentUSA Stock View All
LocationUNITED KINGDOM
Business Address65 Innovation Drive
ExchangeBATS Exchange
CUSIP59564R104
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.midatechpharma.com
Phone44 1235 888 300
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2019
Most Recent QuarterDecember 31, 2017
Last Fiscal Year EndDecember 31, 2017
Date Short InterestAugust 15, 2018

Midatech Pharma Directors

Midatech Pharma Corporate Directors

Simon Turton Senior Independent Non-executive Director
Nicholas RobbinsCherry Finance Director, Director
John Johnston Non-Executive Director
Please see also Stocks Correlation. Please also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of macroaxis ideas.
Search macroaxis.com